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Objectives: The objective of this cross-sectional study was to determine seroprevalence of
hepatitis B surface antigen and related risk factors among new recruits in a military unit in
Turkey.
Methods: Eight thousand ﬁve hundred eighty-nine newly-recruited soldiers were enrolled in
the study. Blood samples were drawn from them between January 2006 and December 2006
and ELISA technique was applied to the samples. In addition, questions on the risk factors
of hepatitis B exposure were asked to the participants in the survey.
Results: The results demonstrated that HBsAg seroprevalence was 2.8%. Further survey
results indicated that seropositivity increased depending on certain risk factors. In multi-
ple regression analysis, signiﬁcant correlations were determined between HBsAg positivity
and certain risk factors such as living in the Southeast Anatolia region (p<0.01), having a
history of living with a hepatitis B carrier (p < 0.001), and presence of a hepatitis B carrier inthe neighborhood or at work (p<0.05).
Conclusions: The HBsAg seropositivity found in this study supports the fact that Turkey
remains in the medium endemicity zone, and that horizontal transmission is predominant.
ual contact is the most common cause. Many studies have
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epatitis B virus (HBV) is a hepatotropic, enveloped and partly
ouble helical DNA virus of genus orthohepadnavirus in the
epadnaviridae family. Owing to its genomic structure com-
osed of only 3200 nucleotides, it is the smallest virus among
ll the known animal DNA viruses. Of all the members of
he hepadnaviridae family, HBV is the only one that causes
1nfection in human beings. It is especially important among
iseases transmitted parenterally. HBV is a virus with 400-
00 million carriers worldwide, chronic at a rate of 5%, and
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Este é um artigo Open Access sob a licençaaccounts for the etiology of 58% of hepatocellular cancer (HCC)
cases.2–4 Thus, it appears to be a signiﬁcant problem threat-
ening public health.
Distribution of HBV infection in the world varies depending
on geographical region, and it is divided into three endemic-
ity zones as low (< 2%), medium (2-7%) and high (≥ 8%).5,6 In
regions where HBV endemicity is low, the probability for an
adult to contract the infection does not exceed 20% and sex-
2,7dicine, Department of Public Health, 32260, Isparta, Turkey.
been conducted to investigate HBV seroprevalence in Turkey,
which shows intermediate endemicity. Medium endemicity
proﬁles are observed in Southern and Eastern Europe, South
 de CC BY-NC-ND
i s . 2012;16(4):339–344
Table 1 – Distribution of the study group according to the
descriptive characteristics.
n %a HBsAg positive
Number %b
District
Urban area 5120 59.6 137 2.7
Rural area 3469 40.4 106 3.1
Region living in
Marmara region 1604 18.7 56 3.5
Aegean region 1058 12.3 20 1.9
Central Anatolia region 1777 20.7 40 2.3
Mediterranean region 1039 12.1 27 2.6
Black Sea region 1112 13.1 29 2.6
East Anatolia region 1015 11.8 22 2.2
Southeast Anatolia region 974 11.3 49 5.0**
Marital status
Married 450 5.2 14 3.1
Bachelor 8119 94.5 229 2.8
Widow 20 0.2 0 0
Educational status
Not literate 33 0.4 2 6.1
Literate 96 1.1 4 4.2
Primary school graduate 1993 23.2 58 2.9
Secondary school graduate 3125 36.4 74 2.4
High-school graduate 2568 29.9 72 2.8
Senior high school graduate 774 9.0 33 4.3
Job
Medicine related 58 0.7 4 6.9
Non-medicine related 8531 99.3 239 2.8
Income level
Very low 543 6.3 17 3.1
Low 1791 20.9 49 2.7
Moderate 5427 63.2 152 2.8
High 791 9.2 23 2.9
Very high 37 0.4 2 5.4
Total 8589 100.0 243 2.8
NS, not signiﬁcant.
∗∗ p<0.01.
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and Central America, and Central Asia and the Middle East,
which includes Turkey. 20-60% of adults in these zones have
anti-HBs positivity. The infection is mostly contracted during
childhood, adolescence or young adulthood, with horizontal
transmission being the most common one. However, there
are other ways through which the virus is transmitted.2,7 In
Africa and Asia, where higher endemicity is observed, the epi-
demiological pattern of HBV is quite different. In these zones,
more than 10% of the community is chronically infected with
HBV and more than 70% of adults have anti-HBs, which indi-
cate a previous HBV infection and subsequent recovery. In
higher endemicity zones perinatal infection is the predomi-
nant mode of transmission followed by horizontal.1,2,7
HBV may be transmitted parenterally, perinatally (verti-
cally), or horizontally (within the family). When parenteral,
sexual, or perinatal transmission is not the case, the pri-
mary means of domestic transmission are saliva or open
injuries.6,8 However, the exact mechanism of domestic trans-
mission of HBVhas not been established yet.8,9 In this country,
common use of personal hygiene materials such as tow-
els, toothbrushes, razors, scissors, or manicure-pedicure kits
within the family, improper disinfection of tools at a barber
or hairdresser, and kissing, which are all means of horizontal
transmission, are the most common ways of contracting the
virus.10
The data in a great number of previous studies conducted
on the prevalence rate of HBV were obtained from blood
donors and risk groups, including healthcare staff.2,11
The objective of this study was to determine the sero-
prevalence of hepatitis B surface antigen (HBsAg) among new
recruits in Turkey, and to investigate the correlation between
risk factors and prevalence of hepatitis B.
Materials and methods
The study population, consisting of 8,589 new recruits, was
randomly selected among the soldiers in amilitary unit,which
is a commando training center, in Isparta (a town in South-
west Turkey). The average age of the study population was
20.5± 1.1 years. Other descriptive characteristics are displayed
on Table 1. The samples in the study were collected from the
same military unit. In Turkey, military service is compulsory,
thus all men who turn 20 are liable for this duty, and trained
for periods ranging from six to 15 months, depending on their
education level. If a young man wants to obtain a university
degree before military service, he may have it postponed until
after graduation.
Turkey is divided into seven geographical regions, which
differ from each other in socio-demographic aspects. In the
military unit where this study was conducted, new recruits
from all seven regions are given military training. Therefore,
the study population represents young men in Turkey who
are liable for compulsory military service. Where a recruit
will perform his military service is randomly determined by
the department of conscription of the Ministry of National
12Defense through a computerized system.
Prior to obtaining the informed consent, the subjects were
given information about the subject of the study, where the
data would be used, and what interventions would be done.percent of column.
b percent of row.
After that, those who agreed to be involved in the study (100%)
were each given a questionnaire to complete. Finally, blood
samples were collected.
Having obtained an informed consent from the recruits
who agreed to participate, data collection was completed
through a questionnaire elaborated by the investigators in
order to determine the socio-demographic aspects and risk
factors of hepatitis B exposure.
The questionnaires contained questions on socio-
demographic characteristics of the individuals (age, gender,
educational status, occupation, income level, number of fam-
ily members sharing the same home, vaccination status for
hepatitis B, and number of doses) and risk factors of hepatitis
B exposure (prior accident, prior blood or blood product trans-
fusion, prior hospitalization, prior parenteral drug therapy,
intravenous narcotic drug use, prior hemodialysis treatment
or surgery, having given a birth, prior dental treatment or cir-
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exual intercourse or contact with an HBV positive individual
r carrier or prior contact with body ﬂuids of any suspected
ndividual, prior manicure-pedicure with contaminated kits,
having with a contaminated razor, common use of bathing
aterials or toothbrushes, living in crowded environments
ith poor sanitary conditions, living with a hepatitis B carrier
n the same home, and presence of a hepatitis B patient or
arrier in the neighborhood, either previously or currently).
In order to determine HBsAg, blood samples of 5mL were
aken fromall the recruitswhohaveﬁlled in thequestionnaire.
articipant’s serum removed by centrifugation at 5,000 rpm
or ﬁve minutes was analyzed for HBsAg by micro ELISA
Abbott/Architect)®. Values between 0-0.04 U/mL were clas-
iﬁed as negative and values ≥ 0.05 U/mL were classiﬁed as
ositive for HBsAg. All individuals found HBsAg positive were
ppropriately referred to care.
This study was conducted in accordance with the ethical
tandards of the Declaration of Helsinki,13 which promotes
espect for all human beings and protects their health and
ights. Prior to the study, the issues concerning the aim of
he study and how the data would be used were explained to
he participants, and an informed consent was obtained. The
urkish Land Forces Command was informed of the study in
dvance, and the study was approved under the authorization
umber LOJ:4013-131-06/Sag˘.D.Rp.ve Sag˘.S¸., of May 22, 2006,
urkish Land Forces Command.
ypothesis of the study
. HBsAg seroprevalence in the study universe is consistent
with the seroprevalence in similar studies conducted pre-
viously in Turkey.
. Prevalence is high among individuals with known risk fac-
tors of hepatitis B exposure.
. There is an association between HBsAg seroprevalence and
certain sociodemographic variables of the individual and of
his family.
The study data were evaluated using the Statistical Pack-
ge for Social Sciences (SPSS 9.0 Inc. California, 1999). The
hi-square test, independent t-test, Pearson’s correlation,
pearman’s correlation, and regression analyseswere used for
tatistical analysis. Signiﬁcant p-value was set at p<0.05.
imitations of the study
. Owing to the limited resources, only HBsAg was evaluated.
However, even if an individual is not HBsAg positive, he/she
may still have had an encounter with HBV. The fact that
parameters such as HBsAb, Anti HBc IgG core total, HBeAg,
HBeAb,AST, andALTwerenot examined, and that the cases
were not classiﬁed in detail (as acute or chronic hepatitis,
active or inactiveHBsAg carrier) are limitations of the study.
. Since the study was conducted in a group of males selected
from among new recruits, the seroprevalence found only
indicates the speciﬁc results for a speciﬁc age group.. In the present study, the data about the risk factors are
reliable only to the extent that the participants were will-
ing to provide the factual information, which is another
limitation. Questions about risk factors such as sexual2;16(4):339–344 341
orientation, drug addiction, etc., may not have been
answered correctly. The sociocultural characteristics of the
participants may have had an effect on their answers.
Results
For the study population, the distribution of hepatitis B sero-
logical test results by region is displayed on Table 1. The
distribution of HBsAg positivity by risk factors related to hep-
atitis B exposure is shown in Table 2. In the study, HBsAg
seroprevalence was found to be 2.8%, and only 7.8% (n=19)
of the HBsAg positive (n=243) had prior knowledge of their
condition.
HBsAg positivity was higher among individuals living in
the Southeast Anatolia region (2 = 27.345, p<0.001). No dif-
ferences were found regarding socio-demographic aspects
(p> 0.05).
HBsAg positivity was higher among individuals who had
had contact with a hepatitis B patient or a carrier (2 = 5.688,
p<0.05), who had lived with a hepatitis B carrier in the same
house (2 = 68.468, p<0.001), who had a hepatitis B carrier
amongneighbors or relatives (2 = 21.250, p<0.001), andwhose
mothers were hepatitis B carriers (2 = 22.828, p<0.01).
Of the study population, 0.8% had been given a single dose,
0.4% a double dose, and 0.6% a triple dose of hepatitis B vac-
cine, adding up to a total of 1.8% with at least one dose of
HBV vaccine. The time from last hepatitis B vaccination in
the vaccinated group was 37.1± 26.5 months (min 4 - max 120
months). There was no signiﬁcant correlation between having
been vaccinated against hepatitis B and HBsAg positivity.
Signiﬁcant variables in univariate analyses (geographical
region, contact with body ﬂuids of a carrier, having mani-
cure/pedicure with kits in common use, living with a carrier,
presence of a hepatitis B carrier in close surroundings, mother
being a hepatitis B patient or carrier) were included in the
multiple regression model (Table 3). A signiﬁcant correlation
was found between living in the Southeast Anatolia region
(=1.8, 95% CI: 1.3-2.5, p < 0.01), having a history of living with
a hepatitis B carrier (=3.8, 95% CI: 2.2-6.5, p < 0.001), and pres-
ence of a hepatitis B carrier close surroundings (=1.6, 95% CI:
1.1-2.5, p < 0.05).
Discussion
HBV infection, which has infected two billion people at some
point in their lives, is a vital problem threatening public health
all over the world. Hepatitis B must be treated seriously owing
to the fact that it sets leads to primary hepatocellular carci-
noma and cirrhosis.5,6,14 The etiology of nearly half of acute
viral hepatitis cases in Turkey is related to HBV (49,6%).15
Screening blood donors for hepatitis and introduction of
single-use injectors have helped to relatively lower the inci-
dence of parenteral contagion. However, HBV still remains a
serious health hazard in developing countries. Studies on hep-
atitis B seroprevalence in Turkey have been conducted among
16,17 18medical staff or among blood donors. Studies involv-
ing a wider public screening for hepatitis B are relatively low
in number.19,20 Public screenings for hepatitis have revealed
that HBsAg positivity ranges from 4% to 9%.8 With regard to
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Table 2 – Distribution of the participants according to risk factors.
n %a HBsAg positive
Number %b
Total 8,589 100.0 243 2.8
Prior accident 1,580 18.4 34 2.2
History of blood transfusion 533 6.2 17 3.2
History of hospitalization 1,915 22.3 57 3.0
History of injections 630 7.3 223 2.8
Use of intravenous narcotic substance 39 0.5 0 0.0
History of hemodialysis 17 0.2 1 5.9
History of surgery 895 10.4 28 3.1
Prior dental treatment 2,442 28.4 78 3.2
Circumcision 8,451 98.4 238 2.8
Ear piercing 140 1.6 2 1.4
Tattoo 135 1.6 1 0.7
Injury by contaminated syringe 76 0.9 1 1.3
Prior sexual experience 5,653 65.8 157 9.4
Contact with hepatitis B patient or carrier 172 2.0 10 5.8*
Manicure/pedicure with equipment in common use 201 2.3 5 2.5
Shaving with equipment in common use 1,063 12.4 31 2.9
Using bathing material, toothbrush in common use 1,064 12.4 23 2.2
Living in crowded places 653 7.6 23 3.5
Living in crowded areas with poor sanitary conditions 798 9.3 25 3.1
Living with a hepatitis B carrier in the same house 189 2.2 24 12.7***
Haepatitis B carrier among neighbors and relatives 647 7.5 37 5.7***
Mother being a hepatitis B carrier 41 0.5 6 14.6**
Prior blood disorders 38 0.4 1 2.6
a percent of column.
b percent of row.
∗ p<0.05.∗∗ p<0.01.
∗∗∗ p<0.001.
hepatitis B virus endemicity, Turkey ranks in the medium
endemicity zone (2%-7%). In this study, HBsAg seropositivity
was found to be 2.8%, which indicates medium endemicity.
Following the multiple analyses in the study, a correlation
between living in Southeast Anatolia and HBsAg positivity
was discovered. Incidence of HBV infections varies depend-
ing on environmental factors, level of education, profession,
and the region’s development status.21 In studies conducted




Region (living in Southeast Anatolia Region: 1,
other: 0)
1.8** (1.3-2.5)
History of contact with body ﬂuids of a
hepatitis B patient/porter (yes: 1, no: 0)
1.0 (0.5-2.0)
History of living with a hepatitis B carrier
(yes: 1, no: 0)
3.8*** (2.2-6.5)
Presence of hepatitis B carrier in close
surroundings (yes: 1, no: 0)
1.6* (1.1-2.5)
Mother with history of a hepatitis B disease or




∗∗∗ p<0.001.in Southeast Anatolia it was reported that HBsAg prevalence
was higher in that region compared to other regions.22–24 In
the present study, the ﬁnding that HBsAg seroprevalence was
meaningfully higher among those who came from Southeast
Anatolia is consistent with the literature. Lack of hygiene
and low socioeconomic status are risk factors for horizontal
contagion.25 The fact that socioeconomic andhumandevelop-
ment parameters in Southeast Anatolia are lower, compared
to the other regions of Turkey, may explain the higher HBsAg
seropositivity in that region.26
Most of the studies that analyzed seroprevalence among
individuals other than donors were conducted among adults
living in urban areas. In some of the rare studies covering both
urban and rural cases, there was not a distinct seropositivity
difference between rural and urban areas, whereas in other
studies HBsAg positivity was higher in urban areas.27 In the
present study, no meaningful difference was found between
rural and urban areas regarding HBsAg positivity.
Sharing the same home with a hepatitis B carrier, or pres-
ence of a hepatitis B carrier in close surroundings are factors
that were found to be related to HBsAg seroprevalence in
multiple analyses, suggesting horizontal contagion. In coun-
tries such as Turkey, where medium endemicity is observed,
horizontal transmission is the primary mode of contagion.28In Turkey, it is thought that HBV is transmitted through all
known modes, with perinatal and horizontal being primary.29
Although the exact mechanism is not known, it is thought
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ygiene materials, and contracting the virus from a contami-
ated surface are factors in such transmissions.30 It is reported
hat horizontal transmission may occur within31 or outside
f the family.32 In the present study, both living in the same
ome as a hepatitis B carrier and presence of a carrier in close
urroundings were found to be related to HBsAg seropositivity.
The World Health Organization (WHO) and the Interna-
ional Labour Organization (ILO) recognized hepatitis B as an
ccupational disease in 1992.18 In the present study, even
hough HBsAg seropositivity was found to be higher among
ealthcare staff compared to other groups, the difference
etermined was not statistically signiﬁcant.
In this study, it was found that a very low percentage (2.0%)
f the study population and of the medical staff (5.2%) had
een vaccinated against hepatitis B. The rate of vaccination
ound in the present study was very low. All babies born after
998, when hepatitis B was included in routine vaccination
rogram, have been vaccinated, under the coverage of the
tate medical insurance. Within the Hepatitis B Control Pro-
ram launched by the Ministry of Health in 2008, adults in the
isk groups are vaccinated at their request. Aiming to increase
he rate of vaccination against hepatitis B among adults, a
atch-up vaccination campaign was initiated in 2009. In that
ampaign, the Ministry of Health planned to determine and
accinate those in the risk groups upon their admission to
ny medical center for any complaint.33 Consequently, the
ate of individuals vaccinated against hepatitis B is increasing
hanks to the introduction of the Hepatitis B Control Program.
owever, this study covers individuals born before the routine
accination against hepatitis B started. Moreover, the study
as conducted prior to the initiation of the program intended
or the vaccination of those in the risk groups because of their
rofessions. The reason for the vaccination rate being so low
ay be explained by the fact that there was no program or
trategy for the risk groups, and individuals could get vacci-
ated at their own discretion by paying out of pocket, which
uggests that prevention of contagious disease may not reach
atisfactory levels if left to individual choice. As a result, con-
rol programs for the prevention of contagious diseases that
hreaten public health must be planned and implemented.
onclusion
epatitis B seroprevalence studies in Turkey are mainly stud-
es conducted among blood donors or risk groups. On the
ther hand, studies conducted among groups other than
hese, which reﬂect a wider population, are limited to regional
tudies. Field studies which can be generalized to the whole
ountry and which show regional differences are very few.
ven though this study was conducted among a certain age
roup consisting only ofmales, itmay still give an insight, for it
as carried out among randomly selected individuals from the
even different geographical regions in Turkey, which enabled
he comparison between regions. More importance must be
ttached to such studies and they must be promoted.The HBsAg seropositivity percentage, which was found at
he conclusion of this study, supports the fact that Turkey
s in a medium endemicity zone. In terms of seropositivity,
here are differences depending on the region, and Southeast
12;16(4):339–344 343
Anatolia has a higher degree of seropositivity. It is believed
that factors related to seropositivity are those of horizontal
transmission. The results of the study suggest that in order
to prevent horizontal transmission, HBsAg positive family
members and students must be screened. In addition, more
attention and training must be given so that people grasp
the vitality of hygiene and prompt vaccination. Through vac-
cination and training programs, the rates of morbidity and
mortality stemming fromhepatitis B and thehigh cost of treat-
ment can be reduced to a minimum.
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